Overview

PacDNA is an oligonucleotide therapeutics company that will expand the horizon of this drug modality to include previously inaccessible organs and tissues. Its proprietary oligonucleotide enhancer technology will be a new drug production engine, producing more potent clinical leads with fewer side effects at a lower cost.

Leadership
  • Chad A. Mirkin, PhD

    Professor

  • Ke Zhang, PhD

    Chief Executive Officer & Professor

See all alumni